Parallel Bio’s head of technology shares a vision for faster, cheaper, and better biological research with human organoids. Ari Gesher, Parallel Bio’s new head of technology, may be new to biotech, but that’s not stopping him from thinking big about disrupting the status quo in biological research. The biotech startup is betting on automation and…
From Palantir to methane-hunting to organoids: Why this tech vet is building a lights-out lab to make drug discovery more like software development
Ari Gesher, a veteran technologist who helped shape SourceForge in its heyday and was a key player at Palantir, the publicly-traded big data analytics company, wants to build a fully automated “lights-off” lab for drug discovery at Parallel Bio. “I’m using our biologists to prototype what the scientific processes are, then we’re going to build…